Literature DB >> 24718028

Association of the HLA-B*52 allele with non-progression to AIDS in Brazilian HIV-1-infected individuals.

S L M Teixeira1, N B R de Sá1, D P Campos2, A B Coelho2, M L Guimarães1, T C N F Leite1, V G Veloso2, M G Morgado1.   

Abstract

Several human leukocyte antigen (HLA) class I alleles are associated with the susceptibility to human immunodeficiency virus-1 (HIV-1) infection and/or AIDS progression. Of these, the HLA-B alleles are considered the strongest genetic determinant of disease outcome. We evaluated the influence of the HLA-B alleles on AIDS progression among HIV-1-positive individuals from Rio de Janeiro, Brazil, who were categorized as rapid progressors (RPs), typical progressors (TPs) or long-term non-progressors (LTNPs). In this study, significant differences in HLA-B allele frequencies were observed among the three progression groups for the B*48, B*49 and B*52 alleles. After controlling for other factors associated with AIDS progression, the presence of the B*52 allele was shown to be a significant protective factor (hazard ratio (HR) 0.49 (95% confidence interval (CI) 0.27-0.90) P<0.03). Although no direct association was observed between the presence of the B*27 or B*57 allele and the LTNP profile compared with the TP or RP groups, the adjusted model confirmed that these alleles are protective factors against AIDS progression (HR 0.62 (95% CI 0.38-0.99) P<0.05), as previously described. These data corroborate the existence of significant differences in HLA-B allele frequencies among the distinct AIDS progression profiles and further elucidate the role of HLA alleles in the outcome of HIV infections in diverse populations.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24718028     DOI: 10.1038/gene.2014.14

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  56 in total

1.  New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS.

Authors:  H Hendel; S Caillat-Zucman; H Lebuanec; M Carrington; S O'Brien; J M Andrieu; F Schächter; D Zagury; J Rappaport; C Winkler; G W Nelson; J F Zagury
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

2.  Elite controllers with low to absent effector CD8+ T cell responses maintain highly functional, broadly directed central memory responses.

Authors:  Zaza M Ndhlovu; Jacqueline Proudfoot; Kevin Cesa; Donna Marie Alvino; Ashley McMullen; Seanna Vine; Eleni Stampouloglou; Alicja Piechocka-Trocha; Bruce D Walker; Florencia Pereyra
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

3.  Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells.

Authors:  Benjamin Descours; Veronique Avettand-Fenoel; Catherine Blanc; Assia Samri; Adeline Mélard; Virginie Supervie; Ioannis Theodorou; Guislaine Carcelain; Christine Rouzioux; Brigitte Autran
Journal:  Clin Infect Dis       Date:  2012-03-22       Impact factor: 9.079

4.  HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication.

Authors:  Olivier Lambotte; Faroudy Boufassa; Yoann Madec; Ahn Nguyen; Cécile Goujard; Laurence Meyer; Christine Rouzioux; Alain Venet; Jean-François Delfraissy
Journal:  Clin Infect Dis       Date:  2005-08-30       Impact factor: 9.079

5.  High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection.

Authors:  R Mariani; F Kirchhoff; T C Greenough; J L Sullivan; R C Desrosiers; J Skowronski
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  Associations between HLA frequencies and pathogenic features of human immunodeficiency virus type 1 infection in seroconverters from the Amsterdam cohort of homosexual men.

Authors:  M R Klein; I P Keet; J D'Amaro; R J Bende; A Hekman; B Mesman; M Koot; L P de Waal; R A Coutinho; F Miedema
Journal:  J Infect Dis       Date:  1994-06       Impact factor: 5.226

7.  Advantage of rare HLA supertype in HIV disease progression.

Authors:  Elizabeth Trachtenberg; Bette Korber; Cristina Sollars; Thomas B Kepler; Peter T Hraber; Elizabeth Hayes; Robert Funkhouser; Michael Fugate; James Theiler; Yen S Hsu; Kevin Kunstman; Samuel Wu; John Phair; Henry Erlich; Steven Wolinsky
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

8.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

9.  Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil.

Authors:  Sylvia Lopes Maia Teixeira; Francisco Inácio Bastos; Mariana A Hacker; Mariza Gonçalves Morgado
Journal:  Infect Genet Evol       Date:  2009-04-05       Impact factor: 3.342

10.  Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers.

Authors:  Zabrina L Brumme; Chun Li; Toshiyuki Miura; Jennifer Sela; Pamela C Rosato; Chanson J Brumme; Tristan J Markle; Eric Martin; Brian L Block; Alicja Trocha; Carl M Kadie; Todd M Allen; Florencia Pereyra; David Heckerman; Bruce D Walker; Mark A Brockman
Journal:  J Acquir Immune Defic Syndr       Date:  2011-02-01       Impact factor: 3.731

View more
  14 in total

1.  Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.

Authors:  Ming-Han Chloe Tsai; Supriya Singh; Emily Adland; Philip Goulder
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles.

Authors:  Fernanda H Côrtes; Caroline Pb Passaes; Gonzalo Bello; Sylvia Lm Teixeira; Carla Vorsatz; Dunja Babic; Mark Sharkey; Beatriz Grinsztejn; Valdilea Veloso; Mario Stevenson; Mariza G Morgado
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-01       Impact factor: 3.731

3.  Viremic control and viral coreceptor usage in two HIV-1-infected persons homozygous for CCR5 Δ32.

Authors:  Timothy J Henrich; Emily Hanhauser; Zixin Hu; Hans-Jürgen Stellbrink; Christian Noah; Jeffrey N Martin; Steven G Deeks; Daniel R Kuritzkes; Florencia Pereyra
Journal:  AIDS       Date:  2015-05-15       Impact factor: 4.177

4.  Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques.

Authors:  Ankita Chowdhury; Timothy L Hayes; Steven E Bosinger; Benton O Lawson; Thomas Vanderford; Joern E Schmitz; Mirko Paiardini; Michael Betts; Ann Chahroudi; Jacob D Estes; Guido Silvestri
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

5.  Analysis of Immunological, Viral, Genetic, and Environmental Factors That Might Be Associated with Decreased Susceptibility to HIV Infection in Serodiscordant Couples in Florianópolis, Southern Brazil.

Authors:  Íris M Santos; Elis A da Rosa; Tiago Gräf; Luiz G E Ferreira; Andrea Petry; Fernanda Cavalheiro; Edna M Reiche; Carlos R Zanetti; Aguinaldo R Pinto
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-21       Impact factor: 2.205

6.  Host genotype and time dependent antigen presentation of viral peptides: predictions from theory.

Authors:  R Charlotte Eccleston; Peter V Coveney; Neil Dalchau
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

7.  Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients.

Authors:  Eva Ramírez de Arellano; Francisco Díez-Fuertes; Francisco Aguilar; Humberto Erick de la Torre Tarazona; Susana Sánchez-Lara; Yolanda Lao; José Luis Vicario; Felipe García; Juan González-Garcia; Federico Pulido; Félix Gutierrez-Rodero; Santiago Moreno; Jose Antonio Iribarren; Pompeyo Viciana; Carlos Vilches; Manuel Ramos; Laura Capa; José Alcamí; Margarita Del Val
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

Review 8.  Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV Infections.

Authors:  Tatiane Assone; Arthur Paiva; Luiz Augusto M Fonseca; Jorge Casseb
Journal:  Viruses       Date:  2016-02-03       Impact factor: 5.048

9.  Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.

Authors:  Diogo Gama Caetano; Fernanda Heloise Côrtes; Gonzalo Bello; Sylvia Lopes Maia Teixeira; Brenda Hoagland; Beatriz Grinsztejn; Valdilea Gonçalves Veloso; Monick Lindenmeyer Guimarães; Mariza Gonçalves Morgado
Journal:  Retrovirology       Date:  2018-09-10       Impact factor: 4.602

10.  The factors associated with natural disease progression from HIV to AIDS in the absence of ART, a propensity score matching analysis.

Authors:  X C Jia; Z H Xia; N Shi; Y P Wang; Z X Luo; Y L Yang; X Z Shi
Journal:  Epidemiol Infect       Date:  2020-02-24       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.